Supernus Pharmaceuticals Correlations

SUPN Stock

USD 36.57 0.42 1.14%

The current 90-days correlation between Supernus Pharmaceuticals and Prestige Brand Holdings is 0.36 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Supernus Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Supernus Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Supernus Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between Supernus Pharmaceuticals and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Supernus Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Supernus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in Supernus Stock, please use our How to Invest in Supernus Pharmaceuticals guide.

Moving together with Supernus Stock

0.79	FNMFO	Federal National Mortgage	Pair Corr
0.62	KB	KB Financial Group	Pair Corr
0.63	TRV	The Travelers Companies Fiscal Year End 17th of January 2025	Pair Corr
0.61	AXP	American Express Fiscal Year End 24th of January 2025	Pair Corr
0.67	CSCO	Cisco Systems Sell-off Trend	Pair Corr
0.83	BAC	Bank of America Aggressive Push	Pair Corr
0.7	CVX	Chevron Corp Sell-off Trend	Pair Corr

Moving against Supernus Stock

0.87	HLN	Haleon plc	Pair Corr
0.75	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.71	BCH	Banco De Chile	Pair Corr
0.67	ANRO	Alto Neuroscience,	Pair Corr
0.61	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.59	SHG	Shinhan Financial	Pair Corr
0.43	BAC-PL	Bank of America	Pair Corr
0.33	WF	Woori Financial Group	Pair Corr
0.71	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.57	VZ	Verizon Communications Sell-off Trend	Pair Corr

Related Correlations Analysis

	PBH	EVO	COLL	DCPH	EGRX	ANIP	PAHC	PCRX	RDY	SSIC
PBH		0.88	-0.87	-0.32	-0.43	0.02	0.46	0.42	-0.78	0.72	PBH
EVO	0.88		-0.89	-0.26	-0.52	-0.21	0.46	0.44	-0.86	0.67	EVO
COLL	-0.87	-0.89		0.26	0.52	0.27	-0.56	-0.49	0.89	-0.62	COLL
DCPH	-0.32	-0.26	0.26		0.31	0.3	-0.28	0.03	0.36	-0.27	DCPH
EGRX	-0.43	-0.52	0.52	0.31		0.34	-0.6	-0.69	0.7	-0.29	EGRX
ANIP	0.02	-0.21	0.27	0.3	0.34		-0.11	0.02	0.43	-0.2	ANIP
PAHC	0.46	0.46	-0.56	-0.28	-0.6	-0.11		0.72	-0.61	0.18	PAHC
PCRX	0.42	0.44	-0.49	0.03	-0.69	0.02	0.72		-0.57	0.12	PCRX
RDY	-0.78	-0.86	0.89	0.36	0.7	0.43	-0.61	-0.57		-0.6	RDY
SSIC	0.72	0.67	-0.62	-0.27	-0.29	-0.2	0.18	0.12	-0.6		SSIC
	PBH	EVO	COLL	DCPH	EGRX	ANIP	PAHC	PCRX	RDY	SSIC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RDY	+ 0.89	COLL
EVO	+ 0.88	PBH
SSIC	+ 0.72	PBH
PCRX	+ 0.72	PAHC
RDY	+ 0.7	EGRX
SSIC	+ 0.67	EVO

High negative correlations

COLL	- 0.89	EVO
COLL	- 0.87	PBH
RDY	- 0.86	EVO
RDY	- 0.78	PBH
PCRX	- 0.69	EGRX
SSIC	- 0.62	COLL

Risk-Adjusted Indicators

There is a big difference between Supernus Stock performing well and Supernus Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Supernus Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PBH	0.94	0.12	0.07	0.29	1.04	(1.01)	1.90	(1.76)	5.58
EVO	4.05	0.66	0.07	(0.64)	5.36	(4.38)	9.82	(8.49)	33.99
COLL	1.87	(0.43)	0.00	(0.24)	0.00	0.00	3.23	(4.47)	12.29
DCPH	1.66	(0.19)	0.00	1.53	0.00	0.00	3.27	(3.25)	9.66
EGRX	3.94	(1.22)	0.00	(7.80)	0.00	0.00	9.24	(8.24)	53.71
ANIP	1.94	(0.28)	0.00	(0.10)	0.00	0.00	3.70	(3.75)	10.82
PAHC	1.81	0.02	0.04	0.14	1.71	(2.08)	3.87	(2.46)	9.05
PCRX	1.92	0.06	0.04	0.18	2.13	(2.08)	3.96	(3.67)	10.38
RDY	0.97	(0.36)	0.00	(0.27)	0.00	0.00	1.50	(2.20)	6.89
SSIC	1.09	0.17	0.02	(1.09)	1.04	(1.35)	2.89	(1.82)	7.09

Supernus Pharmaceuticals Corporate Management

Padmanabh Bhatt	Chief Scientific Officer and Sr. VP of Intellectual Property	Profile
Tami Martin	VP Affairs	Profile
Jeff Bozick	Senior Chain	Profile
Kevin Esq	Compliance Officer	Profile
Taylor Raiford	Senior Sales	Profile
Bryan Roecklein	Senior Development	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC